Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance. J. Can. Res. Updates 2013, 2 (4),  306-317. https://doi.org/10.6000/1929-2279.2013.02.04.9.